OOIR: Observatory of International Research

Papers

(The H4-Index of Current Oncology Reports is 32. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Changing the Perspective on Fertility Preservation for Women with Metastatic or Advanced Stage Cancer	174
Immunotherapeutic and Targeted Strategies for Managing Brain Metastases from Common Cancer Origins: A State-of-the-Art Review	171
Integrating Precision Medicine into the Contemporary Management of Gynecologic Cancers	135
Brain Prehabilitation for Oncologic Surgery	126
Functional Outcomes and Quality of Life in Patients with Sinonasal, Nasopharyngeal, and Anterior Skull Base Tumors	91
NRG1 Fusions: The New Kid on the Block	88
Shifting Epidemiology of Hepatocellular Carcinoma in Far Eastern and Southeast Asian Patients: Explanations and Implications	70
Management of Upper Tract Urothelial Carcinoma	63
The Value Proposition of Observation Medicine in Managing Acute Oncologic Pain	60
Hairy Cell Leukemia (HCL) and HCL Variant: Updates and Spotlights on Therapeutic Advances	58
New Developments in VHL-Associated Neuroendocrine Neoplasms	54
Immunotherapy in Biliary Tract Cancers: Where Are We?	47
Cardiotoxic Effects Following CAR-T Cell Therapy: A Literature Review	47
Advances in Targeted Therapy for Neurofibromatosis Type 2 (NF2)-Associated Vestibular Schwannomas	47
Surgical Management of Melanoma: Advances and Updates	44
Fatty Acid Metabolism and Cancer Immunotherapy	43
Treatment of Metastatic Melanoma in the Elderly	43
Management of In-Transit Metastases	42
AXL Inhibitors: Status of Clinical Development	41
The Provision of Complementary, Alternative, and Integrative Medicine Information and Services: a Review of World Leading Oncology Hospital Websites	41
Development of Delivery Systems for Local Administration of Cytokines/Cytokine Gene-Directed Therapeutics: Modern Oncologic Implications	40
Head and Neck Mucosal Melanoma: Where Are We Now?	38
The Underestimated and Overlooked Burden of Diarrhea and Constipation in Cancer Patients	36
Opportunities and Challenges for a Histology-Agnostic Utilization of Trastuzumab Deruxtecan	35
An Integrated Care Approach to Improve Well-Being in Breast Cancer Patients	35

Surgical Stress and Cancer Progression: New Findings and Future Perspectives	34
“What Should I Eat?”—Addressing Questions and Challenges Related to Nutrition in the Integrative Oncology Setting	34
Cellular Therapy in NSCLC: Between Myth and Reality	33
The Microbiome in Advanced Melanoma: Where Are We Now?	33
The Difficult Airway in Patients with Cancer	33
Current Trends and Challenges of Microbiome Research in Prostate Cancer	33
Anti-PD-1: When to Stop Treatment	32
An Overview of Angiogenesis in Bladder Cancer	32
Engineered T Cells: CAR T Cell Therapy and Beyond	32